Atiqa Khalid
Impact in
- Nephrology top 10%
- Gout, Hyperuricemia, Uric Acid
- Modeling and Simulation top 10%
- COVID-19 epidemiological studies
Papers in
-
- COVID-19 Clinical Research Studies 3
- SARS-CoV-2 and COVID-19 Research 2
-
- COVID-19 and Mental Health 4
- Co-authors
- Sana Ben Ali (5 shared papers)Gülali Aktaş (5 shared papers)Burçin Meryem Atak Tel (3 shared papers)Gizem Bakir Kahveci (2 shared papers)Tuba Taslamacıoğlu Duman (2 shared papers)Özge Kurtkulağı (2 shared papers)Satılmış Bilgin (2 shared papers)İsa Sıncer (1 shared paper)
In The Last Decade
Atiqa Khalid
15 papers receiving 524 citations
Peers
Comparison fields: 5 of 103
- Nephrology 75
- Modeling and Simulation 25
- Infectious Diseases 94
- Oncology 67
- General Dentistry 4
Countries citing papers authored by Atiqa Khalid
This map shows the geographic impact of Atiqa Khalid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atiqa Khalid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atiqa Khalid more than expected).
Fields of papers citing papers by Atiqa Khalid
This network shows the impact of papers produced by Atiqa Khalid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atiqa Khalid. The network helps show where Atiqa Khalid may publish in the future.
Co-authors
The 25 scholars most cited alongside Atiqa Khalid, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 128 | |
| 2 | 2022 | 122 | |
| 3 | 2021 | 100 | |
| 4 | 2021 | 88 | |
| 5 | 2021 | 32 | |
| 6 | 2021 | 21 | |
| 7 | 2023 | 19 | |
| 8 | 2021 | 10 | |
| 9 | 2021 | 8 | |
| 10 | 2025 | 4 | |
| 11 | 2020 | 3 | |
| 12 | COVID-19, Vaccination, and Conspiracies: A Micro-Level Qualitative Study in Islamabad, Pakistan. | 2022 | 3 |
| 13 | 2023 | 2 | |
| 14 | 2022 | 2 | |
| 15 | 2021 | 1 | |
| 16 | 2022 | 0 |
About Atiqa Khalid
Atiqa Khalid is a scholar working on Infectious Diseases, Clinical Psychology, Modeling and Simulation, Oncology and Obstetrics and Gynecology, having authored 16 papers that have together received 543 indexed citations. Recurring topics across this work include COVID-19 and Mental Health (4 papers), Inflammatory Biomarkers in Disease Prognosis (3 papers), COVID-19 Clinical Research Studies (3 papers), COVID-19 epidemiological studies (2 papers), Vaccine Coverage and Hesitancy (2 papers), Misinformation and Its Impacts (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and COVID-19 Pandemic Impacts (2 papers). The work is most often cited by research in Nephrology (75 citations), Modeling and Simulation (25 citations), Infectious Diseases (94 citations), Oncology (67 citations) and General Dentistry (4 citations). Atiqa Khalid has collaborated with scholars based in Pakistan, Türkiye and Lebanon. Frequent co-authors include Sana Ben Ali, Gülali Aktaş, Burçin Meryem Atak Tel, Gizem Bakir Kahveci, Tuba Taslamacıoğlu Duman, Özge Kurtkulağı, Satılmış Bilgin, İsa Sıncer, Yılmaz Güneş and Abdul Waris. Their work appears in journals such as Asian Bioethics Review, Primary care diabetes, World Journal of Diabetes, Journal of Clinical Laboratory Analysis and Environmental Science and Pollution Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.